Management of type 1 diabetes

Area of Science:

• Endocrinology
• Public Health
• Global Health

Background:

• Type 1 diabetes is a global chronic noncommunicable disease with fatal outcomes if untreated.
• Mortality and morbidity in type 1 diabetes are significantly influenced by diagnostic delays and limited access to essential treatments like insulin.
• Effective management of type 1 diabetes is crucial for preventing acute and severe late complications, including cardiovascular issues, kidney failure, and blindness.

Purpose of the Study:

• To highlight the critical factors contributing to mortality in type 1 diabetes, particularly in Africa.
• To emphasize the importance of accessible and affordable diagnostics, insulin, and professional training for managing type 1 diabetes.
• To underscore the role of patient and family education in mitigating the impact of type 1 diabetes and achieving health-related Sustainable Development Goals.

Main Methods:

• The study is a review of existing literature and data on type 1 diabetes management challenges in Africa.
• It synthesizes information on the impact of late diagnosis, insulin access, and healthcare infrastructure on patient outcomes.
• It also considers the necessity of professional training and patient education programs.

Main Results:

• Late diagnosis and lack of affordable insulin access are primary drivers of mortality for people with type 1 diabetes in Africa.
• Availability of diagnostic tools, essential medications, and affordable supplies is critical for reducing mortality and morbidity.
• Comprehensive training for healthcare professionals and robust education for patients and families are essential for effective diabetes management.

Conclusions:

• Addressing barriers to diagnosis, insulin supply, and affordable care is paramount to improving survival rates for type 1 diabetes in Africa.
• Investing in healthcare professional training and patient education programs will lead to better disease control and reduced long-term complications.
• Effective management of type 1 diabetes aligns with global health objectives, including the Sustainable Development Goals and reducing infant mortality.